Phoenix Life Sciences International (Phoenix Life Sciences International) Total Payout Ratio : 0.00 (As of Jun. 10, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Phoenix Life Sciences International Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Phoenix Life Sciences International's current Total Payout Ratio is 0.00.

Phoenix Life Sciences International Total Payout Ratio Historical Data

The historical data trend for Phoenix Life Sciences International's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phoenix Life Sciences International Total Payout Ratio Chart

Phoenix Life Sciences International Annual Data

Trend

Feb11

Feb12

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Total Payout Ratio

Get a 7-Day Free Trial

0.06

0.33

Phoenix Life Sciences International Quarterly Data
	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Aug16	Nov16	Feb17	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Phoenix Life Sciences International's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Phoenix Life Sciences International's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phoenix Life Sciences International's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phoenix Life Sciences International's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Phoenix Life Sciences International's Total Payout Ratio falls into.

Phoenix Life Sciences International Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Phoenix Life Sciences International's Total Payout Ratio for the fiscal year that ended in Feb. 2019 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	1.02	+	0)	/	-3.117
	=	0.33

Phoenix Life Sciences International's Total Payout Ratio for the quarter that ended in Feb. 2019 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	0.205
	=	0.00

Phoenix Life Sciences International Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Phoenix Life Sciences International's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Phoenix Life Sciences International (Phoenix Life Sciences International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phoenix Life Sciences International Ltd (OTCPK:PLSI) » Definitions » Total Payout Ratio

Traded in Other Exchanges

N/A

Address

4262 Blue Diamond Road, Suite 102-277, Las Vegas, NV, USA, 89139

Website

http://www.phoenixlife.co

Phoenix Life Sciences International Ltd is an adaptive healthcare solutions company. Its business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. The company strive to create partnerships and integrate these programs for human health into communities worldwide as part of its Global Health Initiative. Its products include Onco, Metabolic, Transdermal Patche, Medi-Strip Relaxation, and others.